What's new

Summary of opinion: Rheumocam, 13/03/2025 Positive

Summary of opinion: Rheumocam, 13/03/2025 Positive

Mar 14, 2025 - 14:36
 0
Summary of opinion: Rheumocam, 13/03/2025 Positive
Summary of opinion: Rheumocam, 13/03/2025 Positive
Read More

Tags:

Previous Article

First vaccine against epizootic haemorrhagic disease recommended for approval

Next Article

Shareholder Activism – 2024 Review and 2025 Outlook

Related Posts

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Date of authorisation: 03/07/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

Human medicines European public assessment report (EPAR): mResvia, Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 4 February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 February 2025, 11:00 (CET) to 4 February 2025, 11:45 (CET)

Questions and answers clinic on Product Management Serv...

Feb 9, 2025  0